Search Results 301-310 of 10306 for glipizida

  1. Glucarpidase After High-Dose Methotrexate In Patients With Osteosarcoma - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  2. Glioma - Doctors and departments - Mayo Clinic

    Gliomas are the most common brain tumors in adults. Learn more about diagnosis and treatment, including innovative research to find new therapies.

  3. Glioma - Doctors and departments - Mayo Clinic

    Gliomas are the most common brain tumors in adults. Learn more about diagnosis and treatment, including innovative research to find new therapies.

  4. Paliperidone (oral route) - Mayo Clinic

    Paliperidone is used to treat the symptoms of psychotic (mental) disorders, including schizophrenia. It may also be used alone or together with other medicines ...

  5. Glioma - Doctors and departments - Mayo Clinic

    Gliomas are the most common brain tumors in adults. Learn more about diagnosis and treatment, including innovative research to find new therapies.

  6. Glioma - Doctors and departments - Mayo Clinic

    Gliomas are the most common brain tumors in adults. Learn more about diagnosis and treatment, including innovative research to find new therapies.

  7. Glioma - Doctors and departments - Mayo Clinic

    Gliomas are the most common brain tumors in adults. Learn more about diagnosis and treatment, including innovative research to find new therapies.

  8. Glioma - Doctors and departments - Mayo Clinic

    Gliomas are the most common brain tumors in adults. Learn more about diagnosis and treatment, including innovative research to find new therapies.

  9. Glioma - Doctors and departments - Mayo Clinic

    Gliomas are the most common brain tumors in adults. Learn more about diagnosis and treatment, including innovative research to find new therapies.

  10. A Study Of The Efficacy And Safety Of Upadacitinib (ABT-494) In Subjects With Moderately To Severely Active Crohn's Disease Who Have Inadequately Responded To Or Are Intolerant To Conventional Therapies But Have Not Failed Biologic Therapy - Mayo Clinic

    The objective of this study is to evaluate the efficacy and safety of upadacitinib compared to placebo as induction therapy in participants with moderately and ...